Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Neurobiol Dis
    March 2026
  1. HUANG J, Rehman H, Doan C, Stein TD, et al
    Corrigendum to 'Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease' Neurobiology of Disease 219 (2026) Article Number 107257.
    Neurobiol Dis. 2026 Mar 16:107348. doi: 10.1016/j.nbd.2026.107348.
    >> Share

  2. GIUFFRE GM, Scalese A, Quaranta D, Donnarumma F, et al
    The impact of insulin resistance on cognitive impairment and cerebrospinal fluid biomarkers in Alzheimer's disease.
    Neurobiol Dis. 2026;222:107352.
    >> Share

  3. JIANG Z, Saleem K, Fisher E, Li L, et al
    SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients.
    Neurobiol Dis. 2026;221:107345.
    >> Share

    February 2026
  4. CHENG B, Cheng S, Wei W, Pan C, et al
    Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
    Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
    >> Share

  5. RYSKAMP D, Wu L, Wu J, Kim D, et al
    Corrigendum to 'Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor' [Neurobiology of Disease Volume 124 April 2019 Pages 489-504].
    Neurobiol Dis. 2026 Feb 13:107311. doi: 10.1016/j.nbd.2026.107311.
    >> Share

    January 2026
  6. LANZILLOTTA S, Boccardi V, Zulli B, Napoli A, et al
    GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study.
    Neurobiol Dis. 2026;220:107291.
    >> Share

  7. HUANG J, Rehman H, Doan C, Stein TD, et al
    Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease.
    Neurobiol Dis. 2026 Jan 13:107257. doi: 10.1016/j.nbd.2026.107257.
    >> Share

  8. NAGARAJAN V, Libowitz CL, Ackley BD, Wolfe MS, et al
    A C. elegans model of familial Alzheimer's disease shows age-dependent synaptic degeneration independent of amyloid beta-peptide.
    Neurobiol Dis. 2026;219:107267.
    >> Share

  9. ISHIKAWA R, Yamazaki Y, Nakazawa N, Li X, et al
    A novel conditional knock-in mouse model for APOE4-to-APOE3 switching.
    Neurobiol Dis. 2026;218:107244.
    >> Share

    December 2025
  10. BELLOMO G, Toja A, Gaetani L, Nardi G, et al
    Cerebrospinal fluid alpha-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.
    Neurobiol Dis. 2025 Dec 22:107234. doi: 10.1016/j.nbd.2025.107234.
    >> Share

    November 2025
  11. RAFIEE Z, Poceviciute D, Santiago J, Mahmoud R, et al
    CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy.
    Neurobiol Dis. 2025;217:107193.
    >> Share

  12. AUNG KZ, Zin SS, Wu X, Myint ZW, et al
    Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies.
    Neurobiol Dis. 2025;217:107190.
    >> Share

  13. YANG S, Xie B, Liao D, Sun Y, et al
    Trajectory of olfactory cortex degeneration from normal cognition to Alzheimer's disease: Insights from multimodal neuroimaging.
    Neurobiol Dis. 2025;217:107181.
    >> Share

  14. ATTALI RS, Farfara D, Cooper I, Levin A, et al
    Corrigendum to "Naphthoquinone-tyrptophan reduces neurotoxic Abeta*56 levels and improves cognition in Alzheimer's disease animal model" Neurobiol Dis. 46(3) (2012):663-72.
    Neurobiol Dis. 2025 Nov 7:107170. doi: 10.1016/j.nbd.2025.107170.
    >> Share

  15. SCHMEETZ J, van de Sande N, Ramakers IHGB, Verhey FRJ, et al
    Enrichment of phosphorylated Tau 181 levels in tear fluid-derived extracellular vesicles.
    Neurobiol Dis. 2025;216:107134.
    >> Share

  16. XU G, Angelle C, Huilgol D, Sacilotto P, et al
    Comparison of the ApoE allelic variants in the formation of intracerebral Abeta deposits.
    Neurobiol Dis. 2025;216:107105.
    >> Share

  17. MA C, Campbell K, Kovalenko A, Li J, et al
    Nutrient sensing receptor GPRC6A regulates mTORC1 signaling and Tau biology.
    Neurobiol Dis. 2025;216:107054.
    >> Share

    October 2025
  18. ANDRAINI T, Faure LM, Mouledous L, Gauzin S, et al
    Targeting adult-born neurons to correct early deficits in pattern separation in the Tg2576 mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025;217:107158.
    >> Share

  19. WEI J, Xiao T, Lyu J, Zhao Y, et al
    Mitophagy in Alzheimer's disease and its potential as a therapeutic target.
    Neurobiol Dis. 2025 Oct 28:107162. doi: 10.1016/j.nbd.2025.107162.
    >> Share

  20. LIU A, Do Carmo S, Antel JP, Kuhlmann T, et al
    White matter degeneration precedes tau aggregation in rats with Alzheimer's-like tauopathy.
    Neurobiol Dis. 2025;216:107149.
    >> Share

  21. YE Q, Gast G, Holmes TC, Xu X, et al
    Hippocampal neural circuit mechanisms in Alzheimer's disease revealed by viral-genetic circuits mapping.
    Neurobiol Dis. 2025 Oct 11:107139. doi: 10.1016/j.nbd.2025.107139.
    >> Share

  22. WANG Y, Lin J, Qu Y, Ding Y, et al
    Biomarker profile of a Chinese ALS cohort: A comprehensive clinical-biomarkers-imaging analysis.
    Neurobiol Dis. 2025;214:107059.
    >> Share

  23. NEU M, Parfentev I, Potts GK, Stoberl N, et al
    A role for the autophagy receptor NBR1 in the degradation of tau aggregates.
    Neurobiol Dis. 2025;214:107060.
    >> Share

  24. GIANNELLI S, Eroli F, Loera-Valencia R, Leoni V, et al
    Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment.
    Neurobiol Dis. 2025;214:107029.
    >> Share

    September 2025
  25. YU Y, Zhou RZ, Nilsson P, Winblad B, et al
    Altered APP trafficking drives amyloidogenic processing in primary neurons from the App(NL-F) knock-in mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025 Sep 28:107129. doi: 10.1016/j.nbd.2025.107129.
    >> Share

  26. OLAYINKA OA, O'Neill N, Empawi JA, Bock P, et al
    Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer's disease and vascular pathology.
    Neurobiol Dis. 2025 Sep 27:107128. doi: 10.1016/j.nbd.2025.107128.
    >> Share

  27. HEAVENER KS, Tamucci KA, Lee AJ, Kabra K, et al
    P2RX7 modulates the function of human microglia-like cells and mediates the association of IL18 with Alzheimer's disease traits.
    Neurobiol Dis. 2025 Sep 21:107106. doi: 10.1016/j.nbd.2025.107106.
    >> Share

  28. STRINGER CA, Miyasato HKS, Camey KA, Ghadia KA, et al
    Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndrome.
    Neurobiol Dis. 2025 Sep 21:107114. doi: 10.1016/j.nbd.2025.107114.
    >> Share

  29. ANTEQUERA D, Vargas T, Ugalde C, Spuch C, et al
    Retraction notice to "Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease" [Neurobiology of Disease 36 (2009) 42-50].
    Neurobiol Dis. 2025 Sep 11:107088. doi: 10.1016/j.nbd.2025.107088.
    >> Share

  30. ONO K, Noguchi M, Matsumoto Y, Yanase D, et al
    Retraction Notice to "Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro" [Neurobiology of Disease 20 (2005) 233-240].
    Neurobiol Dis. 2025 Sep 11:107087. doi: 10.1016/j.nbd.2025.107087.
    >> Share

  31. KRICK KE, Weekman EM, Johnson SN, Sudduth TL, et al
    Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes.
    Neurobiol Dis. 2025;213:107013.
    >> Share

    August 2025
  32. CHEN Z, Bi S, He HL, Qi Z, et al
    Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease.
    Neurobiol Dis. 2025 Aug 25:107064. doi: 10.1016/j.nbd.2025.107064.
    >> Share

  33. SANTIAGO J, Poceviciute D, Vogel J, Brinkmalm G, et al
    Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study.
    Neurobiol Dis. 2025;215:107057.
    >> Share

  34. FRIDAY CM, Stephens IO, Smith CT, Lee S, et al
    APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses.
    Neurobiol Dis. 2025;212:106983.
    >> Share

    July 2025
  35. SPENCER B, Schueler A, Sung D, Rissman RA, et al
    Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology.
    Neurobiol Dis. 2025;211:106942.
    >> Share

  36. ZARE MS, Abedpoor N, Hajibabaie F, Walker AK, et al
    Gene co-expression patterns shared between chemobrain and neurodegenerative disease models in rodents.
    Neurobiol Dis. 2025;211:106944.
    >> Share

  37. PELAGOTTI V, Plantone D, D'Amico F, Raffa S, et al
    [(18)F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease.
    Neurobiol Dis. 2025 Jul 1:107014. doi: 10.1016/j.nbd.2025.107014.
    >> Share

    June 2025
  38. CHEN KS, Noureldein MH, Rigan DM, Hayes JM, et al
    Interneuron transcriptomics reveals pathologic markers of Alzheimer's disease progression.
    Neurobiol Dis. 2025 Jun 25:107012. doi: 10.1016/j.nbd.2025.107012.
    >> Share

  39. MORAIS RF, Sousa JM, Koba C, Andres L, et al
    Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis.
    Neurobiol Dis. 2025;209:106897.
    >> Share

    May 2025
  40. SORIANO-HERRADOR C, Ubeda-Banon I, Villanueva-Anguita P, Saiz-Sanchez D, et al
    The chaperones HSP90AA1, HSP90AB1 and BAG3 are specifically distributed among human hippocampal subfields during different Alzheimer's disease stages.
    Neurobiol Dis. 2025 May 26:106971. doi: 10.1016/j.nbd.2025.106971.
    >> Share

  41. BADINA AM, Ceyzeriat K, Amosse Q, Tresh A, et al
    Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease.
    Neurobiol Dis. 2025;211:106950.
    >> Share

  42. CERNOTOVA D, Hruzova K, Tous J, Janca R, et al
    Early social deficits in TgF344-AD rats are accompanied by sex-specific parvalbumin-positive interneuron reduction and altered brain oscillations in the hippocampal CA2.
    Neurobiol Dis. 2025;208:106875.
    >> Share

    April 2025
  43. VAN KRUINING D, Losen M, Dehairs J, Swinnen JV, et al
    Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations.
    Neurobiol Dis. 2025 Apr 17:106923. doi: 10.1016/j.nbd.2025.106923.
    >> Share

  44. JOHNSON CN, Evans MR, Blankenship AE, John CS, et al
    Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease.
    Neurobiol Dis. 2025 Apr 16:106916. doi: 10.1016/j.nbd.2025.106916.
    >> Share

  45. SHI J, Zhang M, Hu Y, Liu J, et al
    Differences in transcriptome characteristics and drug repositioning of Alzheimer's disease according to sex.
    Neurobiol Dis. 2025;210:106909.
    >> Share

    March 2025
  46. FATIMA G, Ashiquzzaman A, Kim SS, Kim YR, et al
    Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches.
    Neurobiol Dis. 2025 Mar 17:106877. doi: 10.1016/j.nbd.2025.106877.
    >> Share

  47. TAKEUCHI LE, Kalia LV, Simmons CA
    Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.
    Neurobiol Dis. 2025;208:106864.
    >> Share

  48. PINI L, Brusini L, Griffa A, Cruciani F, et al
    Functional dynamic network connectivity differentiates biological patterns in the Alzheimer's disease continuum.
    Neurobiol Dis. 2025 Mar 11:106866. doi: 10.1016/j.nbd.2025.106866.
    >> Share

  49. WAN L, Zhong P, Li P, Ren Y, et al
    CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model.
    Neurobiol Dis. 2025;206:106826.
    >> Share

    February 2025
  50. VOLLHARDT A, Frolich L, Stockbauer AC, Danek A, et al
    Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.
    Neurobiol Dis. 2025 Feb 23:106845. doi: 10.1016/j.nbd.2025.106845.
    >> Share

  51. SUN YR, Lv QK, Liu JY, Wang F, et al
    New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases.
    Neurobiol Dis. 2025;205:106791.
    >> Share

  52. NAKANO H, Hikishima S, Mori M, Minamikawa J, et al
    Globular-shaped Abeta oligomers have diverse mechanisms for promoting Abeta aggregations with the facilitation of fibril elongation.
    Neurobiol Dis. 2025;205:106775.
    >> Share

    January 2025
  53. MA X, Prokopenko D, Wang N, Aikawa T, et al
    Alzheimer's disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice.
    Neurobiol Dis. 2025;206:106813.
    >> Share

  54. FAURE LMP, Gauzin S, Lejards C, Rampon C, et al
    Fine social discrimination of siblings in mice: Implications for early detection of Alzheimer's disease.
    Neurobiol Dis. 2025 Jan 13:106799. doi: 10.1016/j.nbd.2025.106799.
    >> Share

  55. WANG W, Myers SJ, Ollen-Bittle N, Whitehead SN, et al
    Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025 Jan 8:106798. doi: 10.1016/j.nbd.2025.106798.
    >> Share

  56. ESCARCEGA RD, M J VK, Kyriakopoulos VE, Ortiz GJ, et al
    Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism.
    Neurobiol Dis. 2025;204:106747.
    >> Share

    November 2024
  57. JAHOLKOWSKI P, Bahrami S, Fominykh V, Hindley GFL, et al
    Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain development.
    Neurobiol Dis. 2024 Nov 26:106750. doi: 10.1016/j.nbd.2024.106750.
    >> Share

  58. LIU H, Tan AYS, Mehrabi NF, Turner CP, et al
    Astrocytic proteins involved in regulation of the extracellular environment are increased in the Alzheimer's disease middle temporal gyrus.
    Neurobiol Dis. 2024 Nov 25:106749. doi: 10.1016/j.nbd.2024.106749.
    >> Share

  59. LI N, Wang X, Lin R, Yang F, et al
    ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity.
    Neurobiol Dis. 2024 Nov 20:106741. doi: 10.1016/j.nbd.2024.106741.
    >> Share

    October 2024
  60. MARTINEZ-GARDEAZABAL J, Pereira-Castelo G, Moreno-Rodriguez M, Llorente-Ovejero A, et al
    Sphingosine 1-phosphate receptor subtype 1 (S1P(1)) activity in the course of Alzheimer's disease.
    Neurobiol Dis. 2024 Oct 22:106713. doi: 10.1016/j.nbd.2024.106713.
    >> Share

  61. TANIGUCHI D, Shimonaka S, Imtiaz A, Elahi M, et al
    Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment.
    Neurobiol Dis. 2024;201:106686.
    >> Share

  62. YAMAGUCHI T, Hamano T, Sada K, Asano R, et al
    Syk inhibitors reduce tau protein phosphorylation and oligomerization.
    Neurobiol Dis. 2024;201:106656.
    >> Share

  63. SEKIYA M, Sakakibara Y, Hirota Y, Ito N, et al
    Decreased plasma nicotinamide and altered NAD(+) metabolism in glial cells surrounding Abeta plaques in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Oct 5:106694. doi: 10.1016/j.nbd.2024.106694.
    >> Share

  64. MARMOLEJO-GARZA A, Chatre L, Croteau DL, Herron-Bedoya A, et al
    Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner.
    Neurobiol Dis. 2024;200:106645.
    >> Share

    September 2024
  65. MAGALHAES R, Marques F, Selingue E, Boumezbeur F, et al
    A longitudinal MRI analysis reveals altered brain connectivity and microstructural changes in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Sep 23:106679. doi: 10.1016/j.nbd.2024.106679.
    >> Share

  66. CROCKETT RA, Casselton C, Howard TM, Wilkins KB, et al
    Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease.
    Neurobiol Dis. 2024;201:106677.
    >> Share

  67. ZHUO L, Pang K, Dai J, Wu B, et al
    The neurophysiological mechanisms of medial prefrontal-perirhinal cortex circuit mediating temporal order memory decline in early stage of AD rats.
    Neurobiol Dis. 2024;199:106584.
    >> Share

    August 2024
  68. DOUCETTE L, Turnbill V, Carlin K, Cavanagh A, et al
    Neocortical cholinergic pathology after neonatal brain injury is increased by Alzheimer's disease-related genes in mice.
    Neurobiol Dis. 2024 Aug 5:106629. doi: 10.1016/j.nbd.2024.106629.
    >> Share

  69. CEYZERIAT K, Badina AM, Petrelli F, Montessuit S, et al
    Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024;200:106623.
    >> Share

    July 2024
  70. LOPEZ-CERDAN A, Andreu Z, Hidalgo MR, Soler-Saez I, et al
    An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease.
    Neurobiol Dis. 2024;199:106605.
    >> Share

  71. BUCHANAN RA, Wang Y, May JM, Harrison FE, et al
    Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Jul 12:106602. doi: 10.1016/j.nbd.2024.106602.
    >> Share

    June 2024
  72. LIZAMA BN, North HA, Pandey K, Williams C, et al
    An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease.
    Neurobiol Dis. 2024 Jun 22:106575. doi: 10.1016/j.nbd.2024.106575.
    >> Share

  73. CHANDRASHEKAR DV, Roules GC, Jagadeesan N, Panchal UR, et al
    Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding.
    Neurobiol Dis. 2024 Jun 15:106570. doi: 10.1016/j.nbd.2024.106570.
    >> Share

    May 2024
  74. PAIVA I, Seguin J, Grgurina I, Singh AK, et al
    Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons.
    Neurobiol Dis. 2024 May 22:106538. doi: 10.1016/j.nbd.2024.106538.
    >> Share

  75. CANET G, Gratuze M, Zussy C, Bouali ML, et al
    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
    Neurobiol Dis. 2024 May 9:106526. doi: 10.1016/j.nbd.2024.106526.
    >> Share

  76. XIE B, Yang S, Hao Y, Sun Y, et al
    Impaired olfactory identification in dementia-free individuals is associated with the functional abnormality of the precuneus.
    Neurobiol Dis. 2024;194:106483.
    >> Share

    April 2024
  77. RODRIGUES MES, Bolen ML, Blackmer-Raynolds L, Schwartz N, et al
    Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Apr 24:106511. doi: 10.1016/j.nbd.2024.106511.
    >> Share

  78. LEMCHE E, Killick R, Mitchell J, Caton PW, et al
    Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
    Neurobiol Dis. 2024;196:106485.
    >> Share

  79. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    >> Share

  80. SCHRAEN-MASCHKE S, Duhamel A, Vidal JS, Ramdane N, et al
    The free plasma amyloid Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio. The BALTAZAR study.
    Neurobiol Dis. 2024;193:106459.
    >> Share

  81. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    >> Share

  82. JADHAV VS, Stair JG, Eck RJ, Smukowski SN, et al
    Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.
    Neurobiol Dis. 2024;193:106441.
    >> Share

    March 2024
  83. BONIFAZI G, Luchena C, Gaminde-Blasco A, Ortiz-Sanz C, et al
    A nonlinear meccano for Alzheimer's emergence by amyloid beta-mediated glutamatergic hyperactivity.
    Neurobiol Dis. 2024 Mar 15:106473. doi: 10.1016/j.nbd.2024.106473.
    >> Share

  84. YAMASHIRO K, Takabayashi K, Kamagata K, Nishimoto Y, et al
    Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Neurobiol Dis. 2024 Mar 5:106464. doi: 10.1016/j.nbd.2024.106464.
    >> Share

  85. ZENG J, Liao Z, Yang H, Wang Q, et al
    T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease.
    Neurobiol Dis. 2024;193:106461.
    >> Share

  86. TATO-FERNANDEZ C, Ekblad LL, Pietila E, Saunavaara V, et al
    Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET.
    Neurobiol Dis. 2024;192:106439.
    >> Share

  87. LONG DM, Cravetchi O, Chow ES, Allen C, et al
    The amyloid precursor protein intracellular domain induces sleep disruptions and its nuclear localization fluctuates in circadian pacemaker neurons in Drosophila and mice.
    Neurobiol Dis. 2024;192:106429.
    >> Share

    February 2024
  88. KATSUMATA Y, Wu X, Aung KZ, Gauthreaux K, et al
    Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC.
    Neurobiol Dis. 2024;191:106412.
    >> Share

    January 2024
  89. KOURTI M, Metaxas A
    A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease.
    Neurobiol Dis. 2024 Jan 31:106427. doi: 10.1016/j.nbd.2024.106427.
    >> Share

  90. IVANOVA M, Belaya I, Kucharikova N, de Sousa Maciel I, et al
    Upregulation of Integrin beta-3 in astrocytes upon Alzheimer's disease progression in the 5xFAD mouse model.
    Neurobiol Dis. 2024;191:106410.
    >> Share

  91. GHARPURE M, Vyavahare S, Ahluwalia P, Gupta SK, et al
    Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology.
    Neurobiol Dis. 2024;191:106404.
    >> Share

  92. PIETILA E, Snellman A, Tuisku J, Helin S, et al
    Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation - A 5-year follow-up [(11)C]PIB-PET study.
    Neurobiol Dis. 2024;190:106385.
    >> Share

    December 2023
  93. ZHANG T, Dolga AM, Eisel ULM, Schmidt M, et al
    Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease.
    Neurobiol Dis. 2023 Dec 22:106389. doi: 10.1016/j.nbd.2023.106389.
    >> Share

  94. KOPCANOVA M, Tait L, Donoghue T, Stothart G, et al
    Resting-state EEG signatures of Alzheimer's disease are driven by periodic but not aperiodic changes.
    Neurobiol Dis. 2023 Dec 17:106380. doi: 10.1016/j.nbd.2023.106380.
    >> Share

  95. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    >> Share

  96. HANERT A, Schonfeld R, Weber FD, Nowak A, et al
    Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's disease.
    Neurobiol Dis. 2023 Dec 14:106378. doi: 10.1016/j.nbd.2023.106378.
    >> Share

  97. TIMSINA J, Ali M, Do A, Wang L, et al
    Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification.
    Neurobiol Dis. 2023;190:106373.
    >> Share

    November 2023
  98. NAJAR J, Thorvaldsson V, Kern S, Skoog J, et al
    Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
    Neurobiol Dis. 2023;189:106357.
    >> Share

  99. WOJDALA AL, Bellomo G, Gaetani L, Toja A, et al
    Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP.
    Neurobiol Dis. 2023;189:106356.
    >> Share

  100. LI K, Luo X, Zeng Q, Liu X, et al
    Gray matter structural covariance networks patterns associated with autopsy-confirmed LATE-NC compared to Alzheimer's disease pathology.
    Neurobiol Dis. 2023;189:106354.
    >> Share

    October 2023
  101. GAUTIER MK, Kelley CM, Lee SH, Alldred MJ, et al
    Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of down syndrome and Alzheimer's disease.
    Neurobiol Dis. 2023 Oct 25:106332. doi: 10.1016/j.nbd.2023.106332.
    >> Share

  102. LANOOIJ SD, Drinkenburg WHIM, Eisel ULM, van der Zee EA, et al
    The effects of social environment on AD-related pathology in hAPP-J20 mice and tau-P301L mice.
    Neurobiol Dis. 2023;187:106309.
    >> Share

  103. HIGGINBOTHAM L, Carter EK, Dammer EB, Haque RU, et al
    Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment.
    Neurobiol Dis. 2023;186:106286.
    >> Share

    September 2023
  104. BOTELLO-MARABOTTO M, Martinez-Bisbal MC, Calero M, Bernardos A, et al
    Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease.
    Neurobiol Dis. 2023 Sep 26:106312. doi: 10.1016/j.nbd.2023.106312.
    >> Share

  105. CAO E, Ma D, Nayak S, Duong TQ, et al
    Deep learning combining FDG-PET and neurocognitive data accurately predicts MCI conversion to Alzheimer's dementia 3-year post MCI diagnosis.
    Neurobiol Dis. 2023 Sep 26:106310. doi: 10.1016/j.nbd.2023.106310.
    >> Share

  106. ISRAEL LL, Braubach O, Shatalova ES, Chepurna O, et al
    Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study.
    Neurobiol Dis. 2023;187:106307.
    >> Share

  107. MEDINA-VERA D, Zambrana-Infantes EN, Lopez-Gambero AJ, Verheul-Campos J, et al
    Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice.
    Neurobiol Dis. 2023 Sep 15:106295. doi: 10.1016/j.nbd.2023.106295.
    >> Share

  108. LISGARAS CP, Scharfman HE
    Interictal spikes in Alzheimer's disease: Preclinical evidence for dominance of the dentate gyrus and cholinergic control by medial septum.
    Neurobiol Dis. 2023 Sep 13:106294. doi: 10.1016/j.nbd.2023.106294.
    >> Share

  109. LEITAO ADG, Ahammad RU, Spencer B, Wu C, et al
    Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce alpha-synuclein in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2023;186:106285.
    >> Share

  110. SIGNAL B, Perez Suarez TG, Taberlay PC, Woodhouse A, et al
    Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease.
    Neurobiol Dis. 2023;186:106284.
    >> Share

  111. MEEHAN CE, Schantell M, Springer SD, Wiesman AI, et al
    Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer's disease and HIV-associated neurocognitive disorder.
    Neurobiol Dis. 2023;186:106283.
    >> Share

    August 2023
  112. GIUFFRE GM, Quaranta D, Costantini EM, Citro S, et al
    Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
    Neurobiol Dis. 2023 Aug 29:106267. doi: 10.1016/j.nbd.2023.106267.
    >> Share

  113. DAS M, Mao W, Voskobiynyk Y, Necula D, et al
    Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.
    Neurobiol Dis. 2023 Aug 15:106263. doi: 10.1016/j.nbd.2023.106263.
    >> Share

  114. ARMSTRONG MJ, Jin Y, Vattathil SM, Huang Y, et al
    Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
    Neurobiol Dis. 2023;185:106257.
    >> Share

  115. EMMERSON JT, Do Carmo S, Liu Y, Shalhoub A, et al
    Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
    Neurobiol Dis. 2023;184:106227.
    >> Share

  116. DUMONT M, Agostinis A, Singh K, Swan E, et al
    Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
    Neurobiol Dis. 2023;184:106214.
    >> Share

    July 2023
  117. TROJAN E, Curzytek K, Cieslik P, Wieronska JM, et al
    Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APP(NL-F/NL-F) mouse model of Alzheimer's disease.
    Neurobiol Dis. 2023 Jul 6:106219. doi: 10.1016/j.nbd.2023.106219.
    >> Share

  118. LEGAZ A, Prado P, Moguilner S, Baez S, et al
    Social and non-social working memory in neurodegeneration.
    Neurobiol Dis. 2023;183:106171.
    >> Share

    June 2023
  119. MOWRY FE, Espejo-Porras F, Shijie J, Quadri Z, et al
    Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.
    Neurobiol Dis. 2023 Jun 24:106213. doi: 10.1016/j.nbd.2023.106213.
    >> Share

  120. SUN Y, Bae YE, Zhu J, Zhang Z, et al
    A splicing transcriptome-wide association study identifies novel altered splicing for Alzheimer's disease susceptibility.
    Neurobiol Dis. 2023 Jun 22:106209. doi: 10.1016/j.nbd.2023.106209.
    >> Share

  121. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
    Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
    >> Share

  122. BRADY ES, Griffiths J, Andrianova L, Bielska MH, et al
    Alterations to parvalbumin-expressing interneuron function and associated network oscillations in the hippocampal - medial prefrontal cortex circuit during natural sleep in App(NL-G-F/NL-G-F) mice.
    Neurobiol Dis. 2023;182:106151.
    >> Share

  123. FRANKLIN ZJ, Croce L, Dekeryte R, Delibegovic M, et al
    BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice.
    Neurobiol Dis. 2023;182:106142.
    >> Share

  124. ZOREC R, Vardjan N
    Adrenergic regulation of astroglial aerobic glycolysis and lipid metabolism: Towards a noradrenergic hypothesis of neurodegeneration.
    Neurobiol Dis. 2023;182:106132.
    >> Share

  125. LUTSHUMBA J, Wilcock D, Monson NL, Stowe AM, et al
    Sex-based differences in effector cells of the adaptive immune system during Alzheimer's disease and related dementias.
    Neurobiol Dis. 2023 Jun 15:106202. doi: 10.1016/j.nbd.2023.106202.
    >> Share

  126. PATEL PJ, Ren Y, Yan Z
    Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization.
    Neurobiol Dis. 2023 Jun 9:106192. doi: 10.1016/j.nbd.2023.106192.
    >> Share

  127. FOMINYKH V, Shadrin AA, Jaholkowski PP, Bahrami S, et al
    Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system.
    Neurobiol Dis. 2023 Jun 5:106174. doi: 10.1016/j.nbd.2023.106174.
    >> Share

  128. DE FLORES R, Demeilliez-Servouin S, Kuhn E, Chauveau L, et al
    Respective influence of beta-amyloid and APOE epsilon4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
    Neurobiol Dis. 2023;181:106127.
    >> Share

  129. DUWAT C, Leal P, Vautheny A, Auregan G, et al
    Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathology.
    Neurobiol Dis. 2023;181:106116.
    >> Share

  130. PEDERSEN TJ, Keil SA, Han W, Wang MX, et al
    The effect of aquaporin-4 mis-localization on Abeta deposition in mice.
    Neurobiol Dis. 2023;181:106100.
    >> Share

    May 2023
  131. SNELLMAN A, Ekblad LL, Ashton NJ, Karikari TK, et al
    Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.
    Neurobiol Dis. 2023 May 31:106175. doi: 10.1016/j.nbd.2023.106175.
    >> Share

  132. MUSAEUS CS, Frederiksen KS, Andersen BB, Hogh P, et al
    Detection of subclinical epileptiform discharges in Alzheimer's disease using long-term outpatient EEG monitoring.
    Neurobiol Dis. 2023 May 15:106149. doi: 10.1016/j.nbd.2023.106149.
    >> Share

  133. MABROUK R, Miettinen PO, Tanila H
    Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.
    Neurobiol Dis. 2023;182:106150.
    >> Share

  134. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
    The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
    Neurobiol Dis. 2023;180:106082.
    >> Share

  135. VARBANOV H, Jia S, Kochlamazashvili G, Bhattacharya S, et al
    Rescue of synaptic and cognitive functions in polysialic acid-deficient mice and dementia models by short polysialic acid fragments.
    Neurobiol Dis. 2023;180:106079.
    >> Share

    April 2023
  136. WITTRAHM R, Takalo M, Kuulasmaa T, Makinen PM, et al
    Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPbeta levels in cerebrospinal fluid and 2D/3D cell culture models.
    Neurobiol Dis. 2023;182:106140.
    >> Share

  137. SHIN YJ, Evitts KM, Jin S, Howard C, et al
    Amyloid beta peptides (Abeta) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model.
    Neurobiol Dis. 2023 Apr 14:106125. doi: 10.1016/j.nbd.2023.106125.
    >> Share

  138. LI T, Li D, Wei Q, Shi M, et al
    Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models.
    Neurobiol Dis. 2023 Apr 4:106114. doi: 10.1016/j.nbd.2023.106114.
    >> Share

  139. GRECO GA, Rock M, Amontree M, Lanfranco MF, et al
    CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice.
    Neurobiol Dis. 2023;179:106057.
    >> Share

  140. PRADO P, Moguilner S, Mejia JA, Sainz-Ballesteros A, et al
    Source space connectomics of neurodegeneration: One-metric approach does not fit all.
    Neurobiol Dis. 2023;179:106047.
    >> Share

  141. AFROZ T, Chevalier E, Audrain M, Dumayne C, et al
    Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
    Neurobiol Dis. 2023;179:106050.
    >> Share

    March 2023
  142. RIZZELLO E, Pimpinella D, Pignataro A, Titta G, et al
    Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer's disease mouse model.
    Neurobiol Dis. 2023 Mar 29:106106. doi: 10.1016/j.nbd.2023.106106.
    >> Share

  143. TEIPEL S, Grothe MJ
    MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
    Neurobiol Dis. 2023;180:106070.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016